ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...3334353637383940414243...129130»
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud. (Pubmed Central) -  May 6, 2022   
    In this meta-analysis, the use of ivermectin was not associated with the prevention of RT-PCR-confirmed or symptomatic COVID-19. The currently available randomized trials evaluating ivermectin for the prevention of COVID-19 are insufficient and of poor quality.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition. (Pubmed Central) -  May 5, 2022   
    Moreover, we show that the system can be adapted to report both the function and the chemical inhibition of proteases from different coronavirus species as well as from distantly related viruses. Together with the fact that live cell assays also reflect compound permeability and toxicity, we anticipate that this system will be useful for both identification and optimization of additional coronavirus protease inhibitors.
  • ||||||||||  ivermectin oral / Generic mfg.
    Review, Journal:  Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic. (Pubmed Central) -  May 4, 2022   
    During the initial phase of this pandemic, hydroxychloroquine, ivermectin, azithromycin and doxycycline were widely suggested for possible prophylaxis or treatment for COVID-19 in outpatient as well as hospitalized settings...Antimicrobial resistance (AMR) was one of the top problems for global public health before the coronavirus 2019 (COVID-19) pandemic began. AMR, which is already a difficult problem, must now be handled in the context of a changing healthcare sector.
  • ||||||||||  ivermectin oral / Generic mfg.
    Review, Journal:  Drug safety of frequently used drugs and substances for self-medication in COVID-19. (Pubmed Central) -  May 3, 2022   
    The aim of this review is to describe the available evidence regarding the efficacy, safety, and monitoring of the drugs and substances that have been shown to be frequently used for self-medication in patients with COVID-19 (hydroxychloroquine, non-steroidal anti-inflammatory drugs, ivermectin, azithromycin, vitamins, aspirin, and chlorine dioxide) to adequately characterize their risks, safe use, monitoring strategies, and to reinforce the concept that these substances should not be used for self-medication and require a medical prescription...In this review, we included drugs that are frequently used for self-medication and commonly advertised such as ivermectin, hydroxychloroquine, chlorine dioxide, azithromycin, and non-steroidal anti-inflammatory drugs, among others. A brief introduction of the drug and its mechanism of action, followed by a summary of the efficacy in COVID-19 and safety, will be described for each drug in order to promote their responsible use.
  • ||||||||||  ivermectin oral / Generic mfg., albendazole / Generic mfg.
    Journal:  New 1H-benzimidazole-2-yl hydrazones with combined antiparasitic and antioxidant activity. (Pubmed Central) -  May 3, 2022   
    The anthelmintic activity on encapsulated T. spiralis was studied in vitro thus indicating that all hydrazones were more active than the clinically used anthelmintic drugs albendazole and ivermectin...The relative radical scavenging ability of compounds 5a-l showed a good correlation to the experimentally observed trends. It was found that the studied compounds are capable to react with various free radicals - ˙OCH, ˙OOH and ˙OOCH, through several possible reaction pathways - HAT in nonpolar medium, SPLET in polar medium and RAF in both media.
  • ||||||||||  ivermectin oral / Generic mfg., albendazole / Generic mfg.
    Enrollment open, Trial completion date, Trial primary completion date:  Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (clinicaltrials.gov) -  May 3, 2022   
    P3,  N=100000, Recruiting, 
    It was found that the studied compounds are capable to react with various free radicals - ˙OCH, ˙OOH and ˙OOCH, through several possible reaction pathways - HAT in nonpolar medium, SPLET in polar medium and RAF in both media. Not yet recruiting --> Recruiting | Trial completion date: Mar 2023 --> Mar 2024 | Trial primary completion date: Jun 2022 --> Oct 2022
  • ||||||||||  ivermectin oral / Generic mfg.
    PK/PD data, Preclinical, Journal:  Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment. (Pubmed Central) -  Apr 29, 2022   
    Pharmacokinetic limitations associated with oral ivermectin may limit its success as a potential COVID-19 treatment based on in vitro experiments which demonstrate antiviral efficacy against SARS-CoV-2 at high concentrations...Inhalation delivery of ivermectin formulation showed improved pharmacokinetic performance as it avoided protein binding encountered in systemic delivery and maintained a high exposure above the in vitro antiviral concentration in the respiratory tract for at least 24 hr. The local toxicity was mild with less than 20% of the lung showing histological damage at 24 hr, which resolved to 10% by 48 hr.
  • ||||||||||  ivermectin oral / Generic mfg., ivermectin topical / Generic mfg.
    Journal:  Red blood cells-hitchhiking mediated pulmonary delivery of ivermectin: effects of nanoparticles properties. (Pubmed Central) -  Apr 29, 2022   
    Therefore, RBC-hitchhiking provides an alternative strategy to improve IVM pharmacokinetics and bioavailability for repurposing of IVM to treat COVID-19. Furthermore, according to different redistribution effects of different NPs, RBCs-hitchhiked NPs may achieve various accumulation rates and circulation times for different requirements of drug delivery.
  • ||||||||||  ivermectin oral / Generic mfg.
    Review, Journal:  Strongyloides stercoralis. (Pubmed Central) -  Apr 28, 2022   
    Patients with exposure to endemic areas and those expected to become immune suppressed should be screened and treated before starting immune suppressive agents. Empiric treatment should be considered when timely testing is not readily available.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Black flies and Onchocerciasis: Knowledge, attitude and practices among inhabitants of Alabameta, Osun State, Southwestern, Nigeria. (Pubmed Central) -  Apr 28, 2022   
    Efforts to develop prophylactic and/or therapeutic vaccines for onchocerciasis have been explored since the late 1980s by many researchers and entities, and here we summarize the recent advances made in the development of vaccines against the infection of O. volvulus and onchocerciasis. Due to lack of resident's knowledge on black flies bioecology which may continuously expose them to the bite of the flies and ultimately infection, it is paramount that the Osun State government and the NTD implementing partner map out new public health education strategies during routine Mass Administration of Medicines with Ivermectin with a view to preventing onchocerciasis infection as well as man-vector contact.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  Clinical parameters of hypervirulent Klebsiella pneumoniae disease and ivermectin treatment in New Zealand sea lion (Phocarctos hookeri) pups. (Pubmed Central) -  Apr 27, 2022   
    On comparison of haematological parameters between ivermectin-treated and control pups, significantly lower total plasma protein and higher eosinophil counts were seen in control versus treated pups, however standard length as a surrogate for age was a more important influence on parameters overall than ivermectin treatment. This study also highlighted a cohort of pups with severe clinical signs suggestive of hypervirulent K. pneumoniae infection were lost to follow up at the end of the monitored season, which could be contributing to cryptic juvenile mortality.